<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gomez-Angel AR</submitter><funding>Royal Society</funding><funding>European Commission</funding><funding>UK Research and Innovation</funding><pagination>29292-29303</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12356528</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>147(32)</volume><pubmed_abstract>Fragment-based drug discovery (FBDD) is a key strategy employed in the hit-to-lead phase of pharmaceutical development. The rate-limiting step of this process is often identifying and optimizing synthetic chemistry suitable for fragment elaboration, especially in three dimensions (3-D). To address this limitation, we herein present a modular platform for the systematic and programmable elaboration of two-dimensional (2-D) fragment hits into lead-like 3-D compounds, utilizing nine bifunctional building blocks that explore a range of vectors in 3-D. The building blocks comprise (i) rigid sp&lt;sup>3&lt;/sup>-rich bicyclic cyclopropane-based structures to fix the vectors and (ii) two synthetic handles─a protected cyclic amine and a cyclopropyl &lt;i>N-&lt;/i>methyliminodiacetic acid (MIDA) boronate. To v</pubmed_abstract><journal>Journal of the American Chemical Society</journal><pubmed_title>Modular Synthetic Platform for the Elaboration of Fragments in Three Dimensions for Fragment-Based Drug Discovery.</pubmed_title><pmcid>PMC12356528</pmcid><funding_grant_id>675899, FRAGNET</funding_grant_id><funding_grant_id>INFR1191028</funding_grant_id><funding_grant_id>EP/V048139/1</funding_grant_id><pubmed_authors>Donald JR</pubmed_authors><pubmed_authors>Palmer CJ</pubmed_authors><pubmed_authors>Lincoln J</pubmed_authors><pubmed_authors>Lucas SCC</pubmed_authors><pubmed_authors>Appiani R</pubmed_authors><pubmed_authors>Gomez-Angel AR</pubmed_authors><pubmed_authors>Yao SY</pubmed_authors><pubmed_authors>Fusani L</pubmed_authors><pubmed_authors>Klein HF</pubmed_authors><pubmed_authors>Firth JD</pubmed_authors><pubmed_authors>O'Brien P</pubmed_authors><pubmed_authors>Storer RI</pubmed_authors></additional><is_claimable>false</is_claimable><name>Modular Synthetic Platform for the Elaboration of Fragments in Three Dimensions for Fragment-Based Drug Discovery.</name><description>Fragment-based drug discovery (FBDD) is a key strategy employed in the hit-to-lead phase of pharmaceutical development. The rate-limiting step of this process is often identifying and optimizing synthetic chemistry suitable for fragment elaboration, especially in three dimensions (3-D). To address this limitation, we herein present a modular platform for the systematic and programmable elaboration of two-dimensional (2-D) fragment hits into lead-like 3-D compounds, utilizing nine bifunctional building blocks that explore a range of vectors in 3-D. The building blocks comprise (i) rigid sp&lt;sup>3&lt;/sup>-rich bicyclic cyclopropane-based structures to fix the vectors and (ii) two synthetic handles─a protected cyclic amine and a cyclopropyl &lt;i>N-&lt;/i>methyliminodiacetic acid (MIDA) boronate. To v</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-05-01T18:45:01.919Z</modification><creation>2026-04-07T17:09:33.511Z</creation></dates><accession>S-EPMC12356528</accession><cross_references><pubmed>40737445</pubmed><doi>10.1021/jacs.5c08786</doi></cross_references></HashMap>